A. Yamamoto

Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases.

C. Shields, J. Shields, I. Chervoneva, 2015, Journal of vascular and interventional radiology : JVIR.

The biology and management of uveal melanoma

Takami Sato, F. Han, A. Yamamoto, 2008, Current oncology reports.

A Case of Well-differentiated Hepatocellular Carcinoma that Developed in a Normal Liver of a Young Woman

H. Enzan, M. Toi, A. Yamamoto, 2014 .

Locoregional treatment of malignant hepatic tumors with biologic response modifiers.

Takami Sato, A. Yamamoto, 2008, Surgical oncology clinics of North America.

High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma.

C. Shields, J. Shields, I. Chervoneva, 2009, Radiology.

Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor.

C. Shields, J. Shields, I. Chervoneva, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A pilot study using sunitinib malate as therapy in patients with stage IV uveal melanoma

Takami Sato, M. Mastrangelo, A. Yamamoto, 2008 .

Effect of Multidisciplinary Treatment with High Dose Rate Intraluminal Brachytherapy on Survival in Patients with Unresectable Esophageal Cancer

Y. Ogawa, A. Nishioka, S. Yoshida, 1998, Digestive Surgery.

Carboplatin plus Weekly Paclitaxel with Bevacizumab for First-line Treatment of Non-small Cell Lung Cancer.

A. Yokoyama, F. Ogushi, H. Machida, 2016, Anticancer research.

Cutaneous metastases from pancreatic cancer

Y. Hamanaka, A. Yamamoto, T. Ueno, 1996, International journal of pancreatology : official journal of the International Association of Pancreatology.